BioClinica Names Mukhtar Ahmed as eClinical President
News Apr 24, 2015
BioClinica®, Inc. has announced that Mukhtar Ahmed, a recognized business leader within the life sciences, healthcare and technology sectors, will join BioClinica on April 20th as President of its Global eClinical Business Unit.
Mr. Ahmed most recently served as Global Vice President at Oracle Corporation responsible for growing Global Consulting Services and leading the Life Sciences business toward transformative cloud platforms, big data solutions and digital medicine. During a career spanning more than 25 years in the healthcare research industry, Mr. Ahmed has held senior executive positions with multinational Contract Research Organizations and clinical informatics companies including Kendle, Parexel and Medidata.
"Mukhtar has an exemplary track record delivering significant business benefits and operational growth strategies within the clinical technology sector," BioClinica CEO John Hubbard said. "He has a deep understanding of our business and eClinical customers, making him the right leader to drive new levels of innovation and value in clinical development."
"BioClinica is an industry leader with a comprehensive product platform and technology-enabled services, and I look forward to expanding on this success," Ahmed said. "I'm honored and excited to take on a new role with an organization that has built a reputation for innovation and customer focus."
Mr. Ahmed is an industry advisor to a number of start-ups and mid-range private equity companies and is currently a board advisor for a European laboratory company. He has previously held board-level, non-executive posts with National Health Service primary care and strategic health trusts in the United Kingdom.
Mr. Ahmed is routinely an industry speaker on topics including scientific innovation, strategic outsourcing, business change management, and medical device and clinical technologies. He earned degrees including a B.S. in Applied Systems and an M.S. in Neurological Imaging from Brunel University, as well as an MBA and post graduate diploma in Computer Science from Buckinghamshire University College.
BioClinica will host its annual Trial Blazers Customer Conference in the Orlando, Florida area on May 5 and 6.
In the largest study of its kind, researchers at Newcastle University have led national research into the treatment of patients with newly diagnosed myeloma. The results, published by The Lancet Oncology, show an improvement for those who received ongoing therapy with a drug called lenalidomide, compared to those not receiving it.READ MORE
The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients. Since statins are associated with a low risk of side effects, the benefits of taking them outweigh the risks, according to a scientific statement from the American Heart Association that reviewed multiple studies evaluating the safety and potential side effects of these drugs.READ MORE
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019